Trump’s Pfizer Deal: Protecting Pharma Profits at the Expense of Public Health
-
LN24 / 2 months
- 0
- 2 min read
Pfizer has reached a high-profile agreement with President Donald Trump to reduce Medicaid drug prices in exchange for significant tariff relief. While the administration hails this as a win for patients, it is a misguided deal that mainly protects pharmaceutical profits. The agreement commits Pfizer to price certain medications under Medicaid at rates comparable to […]